Does MEDIUM-CHAIN TRIGLYCERIDES Cause Hypophosphataemia? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Hypophosphataemia have been filed in association with MEDIUM-CHAIN TRIGLYCERIDES. This represents 52.0% of all adverse event reports for MEDIUM-CHAIN TRIGLYCERIDES.
13
Reports of Hypophosphataemia with MEDIUM-CHAIN TRIGLYCERIDES
52.0%
of all MEDIUM-CHAIN TRIGLYCERIDES reports
13
Deaths
11
Hospitalizations
How Dangerous Is Hypophosphataemia From MEDIUM-CHAIN TRIGLYCERIDES?
Of the 13 reports, 13 (100.0%) resulted in death, 11 (84.6%) required hospitalization, and 11 (84.6%) were considered life-threatening.
Is Hypophosphataemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEDIUM-CHAIN TRIGLYCERIDES. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does MEDIUM-CHAIN TRIGLYCERIDES Cause?
Condition aggravated (18)
General physical health deterioration (18)
Hyponatraemia (18)
Multiple organ dysfunction syndrome (18)
Off label use (18)
Sepsis (18)
Somnolence (18)
Stress (18)
Constipation (15)
Drug intolerance (15)
What Other Drugs Cause Hypophosphataemia?
FERRIC CARBOXYMALTOSE (1,046)
ADEFOVIR DIPIVOXIL (368)
DENOSUMAB (322)
ZOLEDRONIC ACID (235)
LAMIVUDINE (205)
CYCLOPHOSPHAMIDE (196)
TENOFOVIR DISOPROXIL (192)
DEXAMETHASONE (186)
ACETAMINOPHEN (169)
LANSOPRAZOLE (159)